UNSPSC 51434961: Amlodipine/Perindopril arginine

Perindopril arginine and amlodipine combination tablets are indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine.

UNSPSC 51434961 Amlodipine/Perindopril arginine is a Commodity code representing a specific pharmaceutical combination product, but the recent state and local contract opportunities solicited under this code show little alignment with the code's nominal scope. The opportunities identified span emergency medical services software (drug-dosage calculation applications), long-term care facility pharmaceutical services, pharmacy benefits program network participation, naloxone distribution, forensic drug reference standards, and EMS supply vending—none of which involves direct procurement of the amlodipine/perindopril combination tablet or capsule. The mismatch suggests either a tagging anomaly in the procurement database or that the code has been applied to broader pharmaceutical procurement categories at the state and local level. Of the recent postings, only the Dane County (Wisconsin) RFP for pharmaceutical services to Badger Prairie Health Care Center and the City of Tucson Fire Department's BLS/ALS pharmaceuticals solicitation represent genuine pharmaceutical product and service procurement, though neither specifies amlodipine/perindopril as a line item.

The issuing bodies span county health authorities, municipal fire departments, state health agencies, and special-purpose districts in Florida, Wisconsin, Arizona, Texas, Oregon, Kentucky, and California. Geographic activity clusters in Florida (Collier County, Seminole County, Clay County, Palm Bay, Marion County), with secondary activity in Wisconsin (Dane County), Arizona (Tucson), Texas (West Texas Centers), Oregon (Washington County), and the District of Columbia. Representative recent opportunities include Dane County's RFP for comprehensive pharmaceutical services to Badger Prairie Health Care Center (due October 22, 2026, with local-vendor preference and annual funding at $125,000) and the City of Tucson Fire Department's RFP for BLS/ALS pharmaceuticals, supplies, and VendNovation software (due June 24, 2026, federally funded through ARPA, HUD, and FTA grants with prevailing wage and DBE requirements). The code shows limited activity tied explicitly to amlodipine/perindopril procurement at the state and local level; firms pursuing this code should verify scope alignment with procurement databases before investing in pursuit strategy.